Folger Hill Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Folger Hill Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-314,057	Closed	-$4.97M	–	234
2017 Q2	$4.97M	Buy	314,057 +164,807	+110%	+$2.39M	0.45%	80
2017 Q1	$2.13M	Buy	+149,250	New	+$2.04M	0.17%	146
2016 Q4	–	Sell	-95,520	Closed	-$1.27M	–	316
2016 Q3	$1.27M	Buy	+95,520	New	+$1.12M	0.08%	207

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Folger Hill Asset Management's IRWD Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2017, closing a stake of 314,057 shares — an estimated $4.97M sold.

Folger Hill Asset Management first reported a position in IRWD in Q3 2016 and held it in 3 quarters. The position peaked at $4.97M in Q2 2017. 149 funds tracked by Wall St. Rank hold IRWD as of Q3 2017.

Folger Hill Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Folger Hill Asset Management sold 314,057 Ironwood Pharmaceuticals shares in Q3 2017, an estimated $4.97M.
Folger Hill Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2016 and held it in 3 quarters.
Folger Hill Asset Management's Ironwood Pharmaceuticals position peaked at $4.97M in Q2 2017.
149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.